Alexandra Potter
Alexandra Potter
Associate Professor of Psychiatry and Psychological Sciences, University of Vermont
Verified email at
Cited by
Cited by
Recruiting the ABCD sample: Design considerations and procedures
H Garavan, H Bartsch, K Conway, A Decastro, RZ Goldstein, S Heeringa, ...
Developmental cognitive neuroscience 32, 16-22, 2018
Image processing and analysis methods for the Adolescent Brain Cognitive Development Study
DJ Hagler Jr, SN Hatton, MD Cornejo, C Makowski, DA Fair, AS Dick, ...
Neuroimage 202, 116091, 2019
Demographic, physical and mental health assessments in the adolescent brain and cognitive development study: Rationale and description
DM Barch, MD Albaugh, S Avenevoli, L Chang, DB Clark, MD Glantz, ...
Developmental cognitive neuroscience 32, 55-66, 2018
Effects of nicotinic stimulation on cognitive performance
PA Newhouse, A Potter, A Singh
Current opinion in pharmacology 4 (1), 36-46, 2004
Nicotinic system involvement in Alzheimer’s and Parkinson’s diseases: implications for therapeutics
PA Newhouse, A Potter, ED Levin
Drugs & aging 11, 206-228, 1997
Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder
AS Potter, PA Newhouse
Psychopharmacology 176, 183-194, 2004
Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer’s disease
A Potter, J Corwin, J Lang, M Piasecki, R Lenox, PA Newhouse
Psychopharmacology 142, 334-342, 1999
Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder
AS Potter, PA Newhouse
Pharmacology Biochemistry and Behavior 88 (4), 407-417, 2008
Acute nicotinic blockade produces cognitive impairment in normal humans
PA Newhouse, A Potter, J Corwin, R Lenox
Psychopharmacology 108 (4), 480-484, 1992
Nicotinic treatment of Alzheimer’s disease
PA Newhouse, A Potter, M Kelton, J Corwin
Biological psychiatry 49 (3), 268-278, 2001
Age-related effects of the nicotinic antagonist mecamylamine on cognition and behavior
PA Newhouse, A Potter, J Corwin, R Lenox
Neuropsychopharmacology 10 (2), 93-107, 1994
Associations among body mass index, cortical thickness, and executive function in children
JS Laurent, R Watts, S Adise, N Allgaier, B Chaarani, H Garavan, A Potter, ...
JAMA pediatrics 174 (2), 170-177, 2020
Central nicotinic cholinergic systems: a role in the cognitive dysfunction in attention-deficit/hyperactivity disorder?
AS Potter, PA Newhouse, DJ Bucci
Behavioural Brain Research 175 (2), 201-211, 2006
Nicotine and nicotinic receptor involvement in neuropsychiatric disorders
P Newhouse, A Singh, A Potter
Current topics in medicinal chemistry 4 (3), 267-282, 2004
Grey matter volume differences associated with extremely low levels of cannabis use in adolescence
C Orr, P Spechler, Z Cao, M Albaugh, B Chaarani, S Mackey, D D'Souza, ...
Journal of Neuroscience 39 (10), 1817-1827, 2019
Association of cannabis use during adolescence with neurodevelopment
MD Albaugh, J Ottino-Gonzalez, A Sidwell, C Lepage, A Juliano, ...
JAMA psychiatry 78 (9), 1031-1040, 2021
Recalibrating expectations about effect size: A multi-method survey of effect sizes in the ABCD study
MM Owens, A Potter, CS Hyatt, M Albaugh, WK Thompson, T Jernigan, ...
PloS one 16 (9), e0257535, 2021
Functional brain imaging of nicotinic effects on higher cognitive processes
PA Newhouse, AS Potter, JA Dumas, CM Thiel
Biochemical pharmacology 82 (8), 943-951, 2011
Baseline brain function in the preadolescents of the ABCD Study
B Chaarani, S Hahn, N Allgaier, S Adise, MM Owens, AC Juliano, ...
Nature neuroscience 24 (8), 1176-1186, 2021
Correspondence between perceived pubertal development and hormone levels in 9-10 year-olds from the adolescent brain cognitive development study
MM Herting, KA Uban, MR Gonzalez, FC Baker, EC Kan, WK Thompson, ...
Frontiers in endocrinology 11, 549928, 2021
The system can't perform the operation now. Try again later.
Articles 1–20